Open AccessProspective controlled trial of immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with systemic sclerosis.
Author(s) -
Percival Degrava Sampaio-Barros,
Ana Cristina Medeiros-Ribeiro,
Ana Paula Luppino Assad,
Renata Miossi,
Henrique Carriço da Silva,
Emily Figueiredo Neves Yuki,
Sandra Gofinet Pasoto,
Carla Gonçalves Schahin Saad,
Clóvis Artur Almeida da Silva,
Léonard de Vinci Kanda Kupa,
Giordano B H Deveza,
Tatiana do Nascimento Pedrosa,
Nádia Emi Aikawa,
Eloísa Bonfá
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.2252
Subject(s) - immunogenicity , virology , medicine , covid-19 , clinical trial , sars virus , immunology , antibody , outbreak , disease , infectious disease (medical specialty)